This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

SAVINGS DEADLINE EXPIRES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center
Book Now
Menu
Book Now

Robert Gronke, PhD
Senior Principal Scientist, Technical Development at Biogen, Inc
Speaker

Profile

Robert Gronke is a Senior Principal Scientist in the Antisense Oligonucleotide department at Biogen. For 34 years, he’s lead the purification process development, CMC leadership, and new technology assessments for Biogen’s commercial ASO products Qalsody and Spinraza along with biological products AVONEX, PLEGRIDY, BENEPALI, plus more than 25 clinical products. Rob currently manages a group of 6 associate scientists.


Prior to joining Biogen, Inc., Dr. Gronke was a post-doctoral fellow in the Pharmacology Department at Merck. He holds a Ph.D. degree in Biochemistry from the University of Kansas, Lawrence Kansas and a BS degree in Biochemistry from Northern Illinois University.

Agenda Sessions

  • Use of Ultrafiltration/Diafiltration for the Processing of Antisense Oligonucleotides

    , 2:30pm
    View Session

At this event

Prev
Next
Brad Grossman
Head of Production Torrance
PolyPeptide Group

See Robert at TIDES USA: Oligonucleotide & Peptide Therapeutics

Book Now